News Sentiment

ELAN sentiment intelligence

Elanco Animal Health news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Weighted score 54 Balanced news tone 58 relevant articles
Exchange NYSE United States
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 24.82 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

79/100 classification confidence.

Company focus 58

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-0.7% over one week, +2.7% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Neutral

How Insider Stock Deferrals and Earnings Buzz At Elanco Animal Health (ELAN) Have Changed Its Investment Story

Market Reaction

Balanced read

52/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 79/100 classification
One-week reaction -0.7% Price digesting
Trend fit Trend inactive 2.7% over four weeks
Fair value 54.4% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 16
Neutral 39
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 58
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 16
Market source 8
simplywall.st 7
TradingView 5
MarketBeat 4
Investing.com Canada 2
MT Newswires 2
CSRwire 1

Event Lens

What the news is about

Classified themes
Market update 31
Earnings 14
Balance sheet 6
Analyst action 4
Regulatory and legal 2
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-58 of 58
Investing.com Canada Direct company coverage

Piper Sandler reiterates Elanco stock rating on defensive positioning By Investing.com

Piper Sandler has reiterated an Overweight rating and a $30.00 price target for Elanco Animal Health due to its defensive positioning in the animal health sector. Despite structural headwinds from declining puppy visits, Elanco is expected to perform better than its peers because

Tone
Positive 72/100
Event
Analyst action
Published
29 Jun 2026 14:41
Source
Investing.com Canada